Investment objective & strategy
As of Feb. 25, 2026 · prospectusObjective. Long -term capital appreciation consistent with reasonable risk to principal.
Strategy. Under normal market circumstances, the Portfolio invests at least 80% of the value of its net assets (including borrowings for investment purposes) in equity securities, such as common stocks and preferred stocks , of U.S. small and medium (SMID) cap companies that Glenmede Investment Management LP (the Advisor) believes are undervalued. SMID cap companies include companies with the market capitalizations, at the time of purchase, that are within the market capitalization range of the smallest stock in the Russell 2500 Index to the largest stock in the Russell Midcap Index. That capitalization range was $ 5.6 million to $ 101.7 billion as of December 31, 2025 . The Advisor uses a combination of quantitative and fundamental research to select securities. … Under normal market circumstances, the Portfolio invests at least 80% of the value of its net assets (including borrowings for investment purposes) in equity securities, such as common stocks and preferred stocks , of U.S. small and medium (SMID) cap companies that Glenmede Investment Management LP (the Advisor) believes are undervalued. SMID cap companies include companies with the market capitalizations, at the time of purchase, that are within the market capitalization range of the smallest stock in the Russell 2500 Index to the largest stock in the Russell Midcap Index. That capitalization range was $ 5.6 million to $ 101.7 billion as of December 31, 2025 . The Advisor uses a combination of quantitative and fundamental research to select securities. The Advisor uses a quantitative proprietary multi-factor computer model which identifies a list of attractive securities having revenue and earnings growth potential with reasonable valuations, then applies fundamental research to select which securities to buy and sell for this Portfolio.
Top holdings
As of April 30, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| WESCO INTL | — | $209.47K | 5.68% |
| GLOBUS MEDICAL INC | — | $177.02K | 4.80% |
| MINERALS TECHNOLOGIES INC | — | $176.47K | 4.79% |
| TRUIST FINL CORP | — | $172.42K | 4.68% |
| ZOOM VIDEO COMMUNICATIONS INC CL A | — | $168.75K | 4.58% |
| EMCOR GROUP INC | — | $168.53K | 4.57% |
| INVENTRUST PROPE | — | $168.47K | 4.57% |
| MGM RESORTS INTERNATIONAL | — | $159.77K | 4.34% |
| CATALYST PHARMACEUTICALS INC | — | $159.41K | 4.33% |
| WORLD KINECT CORP | — | $155.24K | 4.21% |
Portfolio moves
Jan 31, 2026 → Apr 30, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Small Cap Equity Portfolio · GTCSX, GTSCX | 16% | 0.72% |
| Davis Opportunity Fund · RPEAX, DGOCX, DGOYX | 11% | 0.68% |
| Pacer US Cash Cows Growth ETF · BUL | 10% | 0.60% |
Advisers
| Firm | Role |
|---|---|
| Glenmede Investment Management LP | Adviser |
Footnotes
- Expense ratio as of February 25, 2026, from the fund's prospectus.
- Net assets and holdings count as of April 30, 2026, from the fund's N-PORT filing.
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.